Integro Theranostics is a clinical stage company developing fluorescent imaging agents and associated medical devices that enable surgeons to readily see and remove cancerous tissue. This accurate, real-time visualization of cancer tissue facilitates a more complete removal of cancer during surgery. Integro Theranostics was born out of a collaboration between Kingdom Capital (values based private investment company) and Washington University School of Medicine. We are combining the clinical infrastructure of a top research medical center, the technology of a world renowned scientist, and the resources of Kingdom Capital to commercialize this transformative technology and improve surgical outcomes for cancer patients.
| Website | https://integrotheranostics.com/leadership |
| Employees | 8 (3 on RocketReach) |
| Founded | 2020 |
| Address | 16052 Swingley Ridge Rd 300, St. Louis, Missouri 63108, US |
| Industry | Biotechnology Research |
Looking for a particular Integro Theranostics employee's phone or email?
Integro Theranostics Questions
Scott Glover is the CEO of Integro Theranostics.
3 people are employed at Integro Theranostics.
Integro Theranostics is based in St. Louis, Missouri.
Top Integro Theranostics Employees
-
Scott Glover
Chief Executive Officer at Integro Theranostics
St. Louis, MO, US24 -
12
-
Brian Carey
Director of Business Development at Integro Theranostics
Cleveland, OH, US24
